Category Archives: Technology

The Real Way to Lean Success: Suck Out the IT Fat

The bigger the company, the thicker the sclerosis, the more they need to suck out the fat, writes Bill Drummy. Consider this: In 2011, IMS projects US Rx market growth to be 2.7 percent. The top 10 pharma companies account for 50 percent of the entire market’s revenue, but will deliver only 10 percent of the [...]
Also posted in Guest Blog, Strategy | Tagged , , | Leave a comment

The Rise of the Patient: Medicine 2.0

by Sarah Krüg Amidst yellow sandstone arches and California Mission Revival architecture, The Medicine 2.0 +Stanford Summit (otherwise known as the Fourth World Congress on Social Media and Web 2.0 in Health Medicine) set out on a three day journey to challenge its diverse audience to break down silos and expand beyond traditional boundaries. From a [...]
Also posted in Meetings, Patient Communication, Strategy, healthcare, leadership, patient compliance, patient education, social media | Tagged , | Leave a comment

Bringing Genetic Data into the Clinic

While Big Pharma frets over the costs and risks associated with exploratory endpoints in the clinic and the vagaries of companion diagnostic reimbursement, non-profit organizations like the Multiple Myeloma Research Foundation (MMRF) are stepping in to provide pharmacogenomic research for the next generation of cancer drugs.
Also posted in Gene therapy, R&D, Regulatory, Strategy, leadership | Tagged , , | Leave a comment

Pharma Failing to eMarket Effectively

Pharma must overcome its social media phobia and embrace new technology if it wants to keep the audience that matters most, writes Lauren Procter of L2 Think Tank. Consumers and healthcare practitioners have come to rely on digital platforms for medical advice, but as Google trumps nurses, pharmacists, and friends and family as the second most [...]
Also posted in Guest Blog, Strategy, social media | Tagged , , , , | 4 Comments

DIA: Social Media Guidelines are DDMAC’s "Highest Priority"

Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Also posted in Advertising, E-Media, FDA, Marketing, Meetings, Regulatory, Strategy, patient education, social media | Tagged , , | 1 Comment